Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and is listed on The NASDAQ Global Market (the “NASDAQ Stock Market”), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market, nor has the Company received any notification that the SEC or the NASD is contemplating terminating such registration or listing. To the best of the Company’s knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Warburg Pincus Private Equity IX, L.P.), Securities Purchase Agreement (Inspire Pharmaceuticals Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and is listed on The NASDAQ Global National Market (the “"NASDAQ Stock Market”"), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market, nor has the Company received any notification that the SEC or the NASD is contemplating terminating such registration or listing. To the best of the Company’s 's knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Allos Therapeutics Inc), Securities Purchase Agreement (Warburg Pincus Private Equity Viii L P)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, Act and is listed on The NASDAQ Nasdaq Global Market (the “NASDAQ Stock Nasdaq Global Market”), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting de-listing the Common Stock from the NASDAQ Stock Nasdaq Global Market, nor has nor, to the Company received any notification that Company’s knowledge, is the SEC or the NASD is National Association of Securities Dealers, Inc. (the “NASD”) contemplating terminating such registration or listing. To the best of the Company’s knowledge, the The Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Global Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Solexa, Inc.), Securities Purchase Agreement (Illumina Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and is listed on The NASDAQ Global National Market (the “NASDAQ Stock Market”), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock Market, nor has the Company received any notification that the SEC or the NASD is contemplating terminating such registration or listing. To the best of the Company’s knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Stock Market.
Appears in 1 contract
Samples: Securities Purchase Agreement (Allos Therapeutics Inc)
